Osteonecrosis of the jaw and bisphosphonates

BMJ (Online)

Volumn 340, Issue 7743, 2010, Pages 378-

  Khan, Aliya ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

BONE NECROSIS; DOSE RESPONSE; DRUG WITHDRAWAL; EDITORIAL; HUMAN; INCIDENCE; JAW OSTEONECROSIS; NEOPLASM; OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION;

DIPHOSPHONATES; HUMANS; JAW DISEASES; OSTEONECROSIS;

EID: 77149179357     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c246     Document Type: Editorial

References (12)

1. Peters E, Lovas GL, Wysocki GP. Lingual mandibular sequestration and ulceration. Oral Surg Oral Med Oral Pathol 1993;75:739-43.[CrossRef][Web of Science][Medline]
2. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone MinerRes 2007;22:1479-91.[CrossRef]
3. Tosi P, Zamagni E, Cangini D. Bisphosphonates and osteonecrosis of the jaw: incidence in a homogenous series of patients with newly diagnosed multiple myeloma treated with zoledronic acid. Blood 2005;106:3467a.
4. Durie BG, Katz M, Crowley J. Osteonecrosis of the jaws and bisphosphonates. N Engl J Med 2005;353:99-102.[Free Full Text]
5. Cartsos VM, Zhu S, Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714 217 people. J Am Dent Assoc 2008;139:23-30.[Abstract/Free Full Text]
6. Bamias A, Dimopoulos MA. Thalidomide and immunomodulatory drugs in the treatment of cancer. Exp Opin Invest Drugs 2005;14:45-55.[CrossRef]
7. Dimopoulos MA, Kastritis E, Anagnostopoulos A, Melakopoulos I, Gika D, Moulopoulos LA, et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica 2006;91:968-71. [Abstract/Free Full Text]
8. Khan AA, Sandor GK, Dore E, Morrison AD, Alsahli M, Amin F, et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J Rheumatol 2008;35:1391-7. [Abstract/Free Full Text]
9. Felsenberg D, Hoffmeister B, Amling M. Bisphosphonattherapie assoziierte. Kiefernekrosen Deutsches Arzteblatt 2006;46:A3078-80.
10. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral MaxillofacSurg 2007;65:415-23.[CrossRef]
11. Khan AA, Sandor GK, Dore E, Morrison AD, Alshali M, Amin F, et al. Bisphosphonate-associated osteonecrosis of the jaw - literature review. J Rheumatol 2009;36:478-90.[Abstract/Free Full Text]
12. Reid IR, Cundy T. Osteonecrosis of the jaw. Skelet Radiol 2009;12. 38:5-9.[CrossRef]